BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29502123)

  • 1. The Overall Survival Benefit for Patients with T1 Renal Cell Carcinoma after Nephron-Sparing Surgery Depends on Gender and Age.
    Liek E; Elsebach K; Göbel H; Krah X; Krautschick-Wilkens AW; Schweiger J; Steiner G; Steiner T; Wunderlich H
    Urol Int; 2018; 100(3):309-316. PubMed ID: 29502123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
    von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
    Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephron sparing surgery in tumours greater than 7cm.
    de Saint Aubert N; Audenet F; Mccaig F; Delavaud C; Verkarre V; Le Guilchet T; Dariane C; Pettenati C; Slaoui H; Mejean A; Timsit MO
    Prog Urol; 2018 May; 28(6):336-343. PubMed ID: 29699856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff.
    Pignot G; Bigot P; Bernhard JC; Bouliere F; Bessede T; Bensalah K; Salomon L; Mottet N; Bellec L; Soulié M; Ferrière JM; Pfister C; Drai J; Colombel M; Villers A; Rigaud J; Bouchot O; Montorsi F; Bertini R; Belldegrun AS; Pantuck AJ; Patard JJ
    Urol Oncol; 2014 Oct; 32(7):1024-30. PubMed ID: 24996775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
    Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
    Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M; Bratslavsky G
    Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
    Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
    Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcome of Nephron-Sparing Surgery Compared to Radical Nephrectomy for Renal Cell Carcinoma ≥4 cm - A Matched-Pair Single Institution Analysis.
    Kalogirou C; Fender H; Muck P; Hey V; Krebs M; Riedmiller H; Vergho D
    Urol Int; 2017; 98(2):138-147. PubMed ID: 27505105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can partial nephrectomy preserve renal function and modify survival in comparison with radical nephrectomy?
    Medina-Polo J; Romero-Otero J; Rodríguez-Antolín A; Domínguez-Esteban M; Passas-Martínez J; Villacampa-Aubá F; Lora-Pablos D; Gómez De La Cámara A; Díaz-González R
    Scand J Urol Nephrol; 2011 Mar; 45(2):143-50. PubMed ID: 21247272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.
    Kim JK; Kim H; Lee H; Oh JJ; Lee S; Hong SK; Kwak C; Byun SS
    BMC Cancer; 2021 May; 21(1):592. PubMed ID: 34024273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
    An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
    Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.
    Li G; Zhu D; Gao H; Chen H; Li Y; Niu Y
    Clin Transl Oncol; 2019 Jun; 21(6):760-765. PubMed ID: 30443869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
    Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
    Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
    Pertia A; Managadze L; Chkhotua A
    Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
    Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
    BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.